#	Aladdin ID	Assay Type	Description	Organism	Compounds	Reference	BAO Format	Source
1.	ALA706960	F	Inhibition of leukotriene B4 induced intradermal chemotaxis in the guinea pig after 1 hr of administration and before dermal injection of LTB4	Cavia porcellus	1	ALA1124474	organism-based format	Scientific Literature
2.	ALA706961	B	Compound tested for binding affinity against Leukotriene B4 receptor using radioligand binding assay from guinea pig spleen membranes at a concentration of 300 nM.	Cavia porcellus	1	ALA1129645	tissue-based format	Scientific Literature
3.	ALA706962	B	Binding affinity against Leukotriene B4 receptor from guinea pig spleen membranes at a concentration of 30 nM.	Cavia porcellus	18	ALA1129645	tissue-based format	Scientific Literature
4.	ALA706963	B	Capability of compound to inhibit the binding of [3H]LTB4 to guinea pig spleen Leukotriene B4 receptor at the concentration of 10e-5 M	Cavia porcellus	1	ALA1126193	tissue-based format	Scientific Literature
5.	ALA706964	B	Capability to inhibit the binding of [3H]LTB4 to guinea pig spleen Leukotriene B4 receptor at the concentration of 10e-5 M	Cavia porcellus	20	ALA1126193	tissue-based format	Scientific Literature
6.	ALA706965	B	Capability of compound to inhibit the binding of [3H]LTB4 to guinea pig spleen Leukotriene B4 receptors at the concentration of 10e-5 M	Cavia porcellus	1	ALA1126193	tissue-based format	Scientific Literature
7.	ALA706663	F	Duration of action is where maximum inhibition of LTB4 formation is achieved at 0.1 mg/kg po	Canis lupus familiaris	1	ALA1127079	organism-based format	Scientific Literature
8.	ALA706664	F	Duration of action is where maximum inhibition of LTB4 formation is achieved at 0.3 mg/kg po	Canis lupus familiaris	2	ALA1127079	organism-based format	Scientific Literature
9.	ALA706665	F	Duration of action is where maximum inhibition of LTB4 formation is achieved at 1 mg/kg po	Canis lupus familiaris	5	ALA1127079	organism-based format	Scientific Literature
10.	ALA706666	F	Duration of action is where maximum inhibition of LTB4 formation is achieved at 3 mg/kg po	Canis lupus familiaris	2	ALA1127079	organism-based format	Scientific Literature
11.	ALA706667	F	Duration of action where maximum inhibition of LTB4 formation is achieved at 0.1 mg/kg po	Canis lupus familiaris	1	ALA1127079	organism-based format	Scientific Literature
12.	ALA879501	F	Duration of action where maximum inhibition of LTB4 formation is achieved at 0.3 mg/kg po	Canis lupus familiaris	2	ALA1127079	organism-based format	Scientific Literature
13.	ALA706668	F	Duration of action where maximum inhibition of LTB4 formation is achieved at 1 mg/kg iv	Canis lupus familiaris	9	ALA1127079	organism-based format	Scientific Literature
14.	ALA706669	F	Duration of action where maximum inhibition of LTB4 formation is achieved at 1 mg/kg po	Canis lupus familiaris	8	ALA1127079	organism-based format	Scientific Literature
15.	ALA706670	F	Duration of action where maximum inhibition of LTB4 formation is achieved at 10 mg/kg po	Canis lupus familiaris	4	ALA1127079	organism-based format	Scientific Literature
16.	ALA709494	F	Duration of action where maximum inhibition of LTB4 formation is achieved at 1 mg/kg iv	Canis lupus familiaris	1	ALA1127079	organism-based format	Scientific Literature
17.	ALA709495	F	Duration of action where maximum inhibition of LTB4 formation is achieved at 3 mg/kg po	Canis lupus familiaris	4	ALA1127079	organism-based format	Scientific Literature
18.	ALA709496	F	Duration of action where maximum inhibition of LTB4 formation is achieved at 3 mg/kg po	Canis lupus familiaris	1	ALA1127079	organism-based format	Scientific Literature
19.	ALA709497	F	Duration of action where maximum inhibition of LTB4 formation is achieved at 1 mg/kg i.v.	Canis lupus familiaris	1	ALA1127079	organism-based format	Scientific Literature
20.	ALA709498	F	Ex vivo inhibition of LTB-4 determined by measurement of A-23187-stimulated LTB-4 production in dog blood at 0.1 mg/kg po	Canis lupus familiaris	2	ALA1127079	organism-based format	Scientific Literature